Herbert Eradat, MD, MS @dgsomucla Associate Clinical Professor UCLE Lymphoma Program UCLA BMT & CAR-T Cell Program, David Geffen School of Medicine UCLA discusses An Update on Diffuse Large B-Cell Lymphoma Novel Therapeutic Strategies at the MOASC Summit 2020
Sponsors:
AbbVieÂ
AMAG
AstraZenecaÂ
BayerÂ
BeiGeneÂ
Clovis Oncology
CoherusÂ
Daiichi-SankyoÂ
Dova PharmaceuticalsÂ
Foundation MedicineÂ
Jazz Pharmaceuticals Â
MerckÂ
Pfizer OncologyÂ
Puma BiotechnologyÂ
TempusÂ
Verastem oncology
WalgreensÂ
Advertisement